Literature DB >> 33822065

Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan.

Takuya Hara1, Kenji Furuno1, Kenichiro Yamamura2, Junji Kishimoto3, Yumi Mizuno1, Kenji Murata1, Sagano Onoyama4, Ken Hatae4, Megumi Takemoto5, Yoshito Ishizaki6, Shunsuke Kanno7, Kazuo Sato7, Yoshitomo Motomura8, Yasunari Sakai8, Shouichi Ohga8, Mayumi Yashiro9, Yoshikazu Nakamura9, Toshiro Hara1.   

Abstract

Importance: The development of Kawasaki disease (KD) has been suggested to be associated with droplet- or contact-transmitted infection; however, its triggers and transmission modes remain to be determined. Under an epidemic of SARS-CoV-2, the COVID-19 state of emergency in Japan served as a nationwide social experiment to investigate the impact of quarantine or isolation on the incidence of KD. Objective: To assess the role of droplet or contact transmission in the etiopathogenesis of KD. Design, Setting, and Participants: This multicenter, longitudinal, cross-sectional study was conducted from 2015 to 2020 at Fukuoka Children's Hospital and 5 adjacent general hospitals. The number of admissions for KD and infectious diseases were analyzed. Participants were pediatric patients admitted to the participating hospitals for KD or infectious diseases. Exposures: Quarantine and isolation owing to the COVID-19 state of emergency. Main Outcomes and Measures: The primary end points were the ratios of patients with KD to patients with respiratory tract or gastrointestinal infections admitted from April to May in 2015 to 2019 and 2020. A Poisson regression model was used to analyze them.
Results: The study participants included 1649 patients with KD (median [interquartile range] age, 25 [13-43] months; 901 boys [54.6%]) and 15 586 patients with infectious disease (data on age and sex were not available for these patients). The number of admissions for KD showed no significant change between April and May in 2015 to 2019 vs the same months in 2020 (mean [SD], 24.8 [5.6] vs 18.0 [4.0] admissions per month; 27.4% decrease; adjusted incidence rate ratio [aIRR], 0.73; 95% CI, 0.48-1.10; P = .12). However, the number of admissions for droplet-transmitted or contact-transmitted respiratory tract infections (mean [SD], 157.6 [14.4] vs 39.0 [15.0] admissions per month; 75.3% decrease; aIRR, 0.25; 95% CI, 0.17-0.35; P < .001) and gastrointestinal infections (mean [SD], 43.8 [12.9] vs 6.0 [2.0] admissions per month; 86.3% decrease; aIRR, 0.14; 95% CI, 0.04-0.43; P < .001) showed significant decreases between April and May in 2015 to 2019 vs the same months in 2020 (total, 12 254 infections). Thus, the ratio of KD to droplet- or contact-transmitted respiratory tract and gastrointestinal infections incidence in April and May 2020 was significantly increased (ratio, 0.40 vs 0.12; χ21 = 22.76; P < .001). Conclusions and Relevance: In this study, the significantly increased incidence of KD compared with respiratory tract and gastrointestinal infections during the COVID-19 state of emergency suggests that contact or droplet transmission is not a major route for KD development and that KD may be associated with airborne infections in most cases.

Entities:  

Mesh:

Year:  2021        PMID: 33822065     DOI: 10.1001/jamanetworkopen.2021.4475

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  9 in total

1.  Epidemiological and Clinical Features of Kawasaki Disease During the COVID-19 Pandemic in the United States.

Authors:  Jennifer A Burney; Samantha C Roberts; Laurel L DeHaan; Chisato Shimizu; Emelia V Bainto; Jane W Newburger; Samuel Dominguez; Pei-Ni Jone; Preeti Jaggi; Jacqueline R Szmuszkovicz; Anne H Rowley; Nichole Samuy; Paul Scalici; Adriana H Tremoulet; Daniel R Cayan; Jane C Burns
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis.

Authors:  Kyunghoon Kim; Hyun Hee Kim; Beom Joon Kim; Arum Choi; Hwan Soo Kim; Jin-Hee Oh; Jae-Young Lee; Sukil Kim; Ji-Whan Han
Journal:  J Korean Med Sci       Date:  2022-05-23       Impact factor: 5.354

3.  Kawasaki Disease and Infections: A Myth or a Reality?

Authors:  Anju Gupta
Journal:  Indian J Pediatr       Date:  2022-05-30       Impact factor: 5.319

4.  Error in Discussion.

Authors: 
Journal:  JAMA Netw Open       Date:  2021-05-03

5.  Kawasaki Disease Hospitalizations in the United States 2016-2020: A Comparison of Before and During the Coronavirus Disease 2019 Era.

Authors:  Timothy T Phamduy; Sharon Smith; Katherine W Herbst; Paul T Phamduy; Michael Brimacombe; Alexander H Hogan; Juan C Salazar; Jesse Sturm
Journal:  Pediatr Infect Dis J       Date:  2021-11-01       Impact factor: 3.806

6.  Number of Kawasaki Disease Admissions Is Associated with Number of Domestic COVID-19 and Severe Enterovirus Case Numbers in Taiwan.

Authors:  Mindy Ming-Huey Guo; Kuender D Yang; Shih-Feng Liu; Ho-Chang Kuo
Journal:  Children (Basel)       Date:  2022-01-24

Review 7.  Global epidemiology of vasculitis.

Authors:  Richard A Watts; Gulen Hatemi; Jane C Burns; Aladdin J Mohammad
Journal:  Nat Rev Rheumatol       Date:  2021-12-01       Impact factor: 20.543

8.  Decreased number of inpatients with community-acquired pneumonia during the COVID-19 pandemic: A large multicenter study in Japan.

Authors:  Yan Yan; Kiyohide Tomooka; Toshio Naito; Takeshi Tanigawa
Journal:  J Infect Chemother       Date:  2022-01-21       Impact factor: 2.211

9.  Multi-inflammatory syndrome and Kawasaki disease in children during the COVID-19 pandemic: A nationwide register-based study and time series analysis.

Authors:  Ulla Koskela; Otto Helve; Emmi Sarvikivi; Merja Helminen; Tea Nieminen; Ville Peltola; Marjo Renko; Harri Saxén; Hanna Pasma; Tytti Pokka; Minna Honkila; Terhi Tapiainen
Journal:  Acta Paediatr       Date:  2021-08-04       Impact factor: 4.056

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.